Cargando…
Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice
Many patients with diabetic eye disease respond inadequately to anti-VEGF therapies, implicating additional vasoactive mediators in its pathogenesis. We demonstrate that levels of angiogenic proteins regulated by HIF-1 and -2 remain elevated in the eyes of people with diabetes despite treatment with...
Autores principales: | Zhang, Jing, Sharma, Deepti, Dinabandhu, Aumreetam, Sanchez, Jaron, Applewhite, Brooks, Jee, Kathleen, Deshpande, Monika, Flores-Bellver, Miguel, Hu, Ming-Wen, Guo, Chuanyu, Salman, Shaima, Hwang, Yousang, Anders, Nicole M., Rudek, Michelle A., Qian, Jiang, Canto-Soler, M. Valeria, Semenza, Gregg L., Montaner, Silvia, Sodhi, Akrit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313368/ https://www.ncbi.nlm.nih.gov/pubmed/37227777 http://dx.doi.org/10.1172/JCI163290 |
Ejemplares similares
-
ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization
por: Qin, Yu, et al.
Publicado: (2022) -
HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy
por: Salman, Shaima, et al.
Publicado: (2022) -
Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy
por: Jee, Kathleen, et al.
Publicado: (2017) -
Lack of Evidence for Vasoactive and Inflammatory Mediators in the Promotion of Macular Edema Associated with Epiretinal Membranes
por: Applewhite, Brooks P., et al.
Publicado: (2017) -
Aqueous proteins help predict the response of patients with neovascular age-related macular degeneration to anti-VEGF therapy
por: Cao, Xuan, et al.
Publicado: (2022)